NEW YORK (GenomeWeb News) – Barcelona's Centre for Genomic Regulation announced on Tuesday a one-year collaboration with Illumina.
The center provided few details about the collaboration and did not respond to a request for comment. In a statement, it said that the deal paves "the way for molecular medicine" and could transform healthcare.
"This is the first step in a joint working relationship, which I believe could be very fruitful, and which opens the door to more applied collaborations in the field of genomics, including the study of genetic diseases," Luis Serrano, CRG's director, said in the statement.
CRG said that the deal aligns with its strategy to foster collaboration between itself and commercial enterprises.
"These kinds of alliances, and partnerships with hospitals, other research institutes and patient associations, are exactly what the CRG hopes to foster, as they are essential in attracting private funding and the development of a new economic model based on knowledge and innovation," it said.
Earlier this month, the center announced a deal with Sanofi directed at research projects in medical genetics, epigenetics, and computational biology.